Michael Todisco - Net Worth and Insider Trading
Michael Todisco Net Worth
The estimated net worth of Michael Todisco is at least $4 Million dollars as of 2024-11-13. Michael Todisco is the Vice President, Controller of Davis Select U.S. Equity ETF and owns about 98,942 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $4 Million. Details can be seen in Michael Todisco's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Todisco has not made any transactions after 2011-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Todisco
Michael Todisco Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Todisco owns 1 companies in total, including Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Michael Todisco’s form 4 insider trades.
Insider Ownership Summary of Michael Todisco
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2017-04-03 | VP & Finance & Assistant Treas |
Michael Todisco Latest Holdings Summary
Michael Todisco currently owns a total of 1 stock. Michael Todisco owns 98,942 shares of Davis Select U.S. Equity ETF (DUSA) as of May 12, 2011, with a value of $4 Million.
Latest Holdings of Michael Todisco
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DUSA | Davis Select U.S. Equity ETF | 2011-05-12 | 98,942 | 44.18 | 4,371,258 |
Holding Weightings of Michael Todisco
Michael Todisco Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Todisco has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the sale of 27,800 shares on May 12, 2011, which brought Michael Todisco around $164,298.
Insider Trading History of Michael Todisco
- 1
Michael Todisco Trading Performance
Michael Todisco Ownership Network
Ownership Network List of Michael Todisco
Ownership Network Relation of Michael Todisco
Michael Todisco Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Michael Todisco is the VP & Finance & Assistant Treas of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Michael Todisco made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,682 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 27,326 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 27,326 shares. During the past 18 months, 2,078,182 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,037,042 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Michael Todisco Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Todisco. You might contact Michael Todisco via mailing address: C/o Dusa Pharmaceuticals, Inc., 25 Upton Drive, Wilmington Ma 01887.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
